{"version":"1.0","provider_name":"Stoxpo","provider_url":"https:\/\/stoxpo.com","author_name":"Luca Blaumann","author_url":"https:\/\/stoxpo.com\/index.php\/author\/luca-blaumann\/","title":"Biotech Stocks Slide as FDA\u2019s Peter Marks Resigns - Stoxpo","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"yG4rYkpPGt\"><a href=\"https:\/\/stoxpo.com\/index.php\/2025\/03\/31\/biotech-stocks-slide-as-fdas-peter-marks-resigns\/\">Biotech Stocks Slide as FDA\u2019s Peter Marks Resigns<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/stoxpo.com\/index.php\/2025\/03\/31\/biotech-stocks-slide-as-fdas-peter-marks-resigns\/embed\/#?secret=yG4rYkpPGt\" width=\"600\" height=\"338\" title=\"&#8220;Biotech Stocks Slide as FDA\u2019s Peter Marks Resigns&#8221; &#8212; Stoxpo\" data-secret=\"yG4rYkpPGt\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/stoxpo.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-edward-jenner-4033148-scaled.jpg","thumbnail_width":2560,"thumbnail_height":1706,"description":"Wall Street Reacts to Leadership Uncertainty in Biopharma Approvals The resignation of Peter Marks, director of the FDA\u2019s Center for Biologics Evaluation and Research (CBER), sent biotech stocks tumbling on Monday, as investors worried about the future of regulatory approvals in the sector. Marks, who played a key role in approving COVID-19 and RSV vaccines, [&hellip;]"}